Compare MCRB & MBBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MCRB | MBBC |
|---|---|---|
| Founded | 2010 | 1902 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.2M | 44.1M |
| IPO Year | 2015 | 2020 |
| Metric | MCRB | MBBC |
|---|---|---|
| Price | $2.53 | $14.84 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $17.00 | N/A |
| AVG Volume (30 Days) | ★ 72.7K | 3.6K |
| Earning Date | 11-04-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3200.00 |
| EPS | N/A | ★ 0.66 |
| Revenue | ★ $789,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $22.76 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.42 | $10.53 |
| 52 Week High | $29.98 | $15.79 |
| Indicator | MCRB | MBBC |
|---|---|---|
| Relative Strength Index (RSI) | 21.14 | 38.21 |
| Support Level | N/A | $14.58 |
| Resistance Level | $9.53 | $15.39 |
| Average True Range (ATR) | 0.24 | 0.14 |
| MACD | -0.04 | -0.03 |
| Stochastic Oscillator | 7.70 | 8.56 |
Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.
Marathon Bancorp Inc is a mid-tier holding company for Marathon Bank, a Wisconsin-chartered savings bank. The group operates as a community-oriented bank offering a variety of financial products and services to meet the needs of customers. The primary deposit products are demand deposits, savings, and certificates of deposits; and prime lending products are commercial real estate, commercial and industrial, construction, one-to-four-family residential, multifamily real estate, and consumer loans. The majority of the group's revenue comes from interest income on loans and debt securities.